JPS4828654A - - Google Patents

Info

Publication number
JPS4828654A
JPS4828654A JP46064203A JP6420371A JPS4828654A JP S4828654 A JPS4828654 A JP S4828654A JP 46064203 A JP46064203 A JP 46064203A JP 6420371 A JP6420371 A JP 6420371A JP S4828654 A JPS4828654 A JP S4828654A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP46064203A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP46064203A priority Critical patent/JPS4828654A/ja
Publication of JPS4828654A publication Critical patent/JPS4828654A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Cereal-Derived Products (AREA)
JP46064203A 1971-08-23 1971-08-23 Pending JPS4828654A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP46064203A JPS4828654A (en) 1971-08-23 1971-08-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46064203A JPS4828654A (en) 1971-08-23 1971-08-23

Publications (1)

Publication Number Publication Date
JPS4828654A true JPS4828654A (en) 1973-04-16

Family

ID=13251261

Family Applications (1)

Application Number Title Priority Date Filing Date
JP46064203A Pending JPS4828654A (en) 1971-08-23 1971-08-23

Country Status (1)

Country Link
JP (1) JPS4828654A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230100940A1 (en) * 2016-03-07 2023-03-30 Mitochon Pharmaceuticals, Inc. DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230100940A1 (en) * 2016-03-07 2023-03-30 Mitochon Pharmaceuticals, Inc. DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases

Similar Documents

Publication Publication Date Title
ATA136472A (en)
AR196074A1 (en)
AU2658571A (en)
AU2691671A (en)
AU2952271A (en)
AU2564071A (en)
JPS4828654A (en)
AU2485671A (en)
AU2684071A (en)
AU2486471A (en)
AU3025871A (en)
AR199640Q (en)
AR202997Q (en)
AR192311Q (en)
AU2577671A (en)
AU1109576A (en)
AU2503871A (en)
AU2963771A (en)
AU2726271A (en)
AU2399971A (en)
AU2473671A (en)
AU2724971A (en)
AU2684171A (en)
AU3038671A (en)
AU2654071A (en)